136 related articles for article (PubMed ID: 32736766)
1. Coagulation signaling and cancer immunotherapy.
Ruf W; Graf C
Thromb Res; 2020 Jul; 191 Suppl 1():S106-S111. PubMed ID: 32736766
[TBL] [Abstract][Full Text] [Related]
2. Roles of factor Xa beyond coagulation.
Ruf W
J Thromb Thrombolysis; 2021 Aug; 52(2):391-396. PubMed ID: 33893900
[TBL] [Abstract][Full Text] [Related]
3. Myeloid cell-synthesized coagulation factor X dampens antitumor immunity.
Graf C; Wilgenbus P; Pagel S; Pott J; Marini F; Reyda S; Kitano M; Macher-Göppinger S; Weiler H; Ruf W
Sci Immunol; 2019 Sep; 4(39):. PubMed ID: 31541031
[TBL] [Abstract][Full Text] [Related]
4. Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases.
Posma JJ; Grover SP; Hisada Y; Owens AP; Antoniak S; Spronk HM; Mackman N
Arterioscler Thromb Vasc Biol; 2019 Jan; 39(1):13-24. PubMed ID: 30580574
[TBL] [Abstract][Full Text] [Related]
5. Coagulation Factor Xa and Protease-Activated Receptor 2 as Novel Therapeutic Targets for Diabetic Nephropathy.
Oe Y; Hayashi S; Fushima T; Sato E; Kisu K; Sato H; Ito S; Takahashi N
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1525-33. PubMed ID: 27283743
[TBL] [Abstract][Full Text] [Related]
6. Coagulation factor Xa induces an inflammatory signalling by activation of protease-activated receptors in human atrial tissue.
Bukowska A; Zacharias I; Weinert S; Skopp K; Hartmann C; Huth C; Goette A
Eur J Pharmacol; 2013 Oct; 718(1-3):114-23. PubMed ID: 24041930
[TBL] [Abstract][Full Text] [Related]
7. Nonhemostatic Activities of Factor Xa: Are There Pleiotropic Effects of Anti-FXa Direct Oral Anticoagulants?
Papadaki S; Tselepis AD
Angiology; 2019 Nov; 70(10):896-907. PubMed ID: 31010298
[TBL] [Abstract][Full Text] [Related]
8. Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis.
Strukova S
Front Biosci; 2006 Jan; 11():59-80. PubMed ID: 16146714
[TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban, a specific FXa inhibitor, improved endothelium-dependent relaxation of aortic segments in diabetic mice.
Pham PT; Fukuda D; Yagi S; Kusunose K; Yamada H; Soeki T; Shimabukuro M; Sata M
Sci Rep; 2019 Aug; 9(1):11206. PubMed ID: 31371788
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa.
Camerer E; Huang W; Coughlin SR
Proc Natl Acad Sci U S A; 2000 May; 97(10):5255-60. PubMed ID: 10805786
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a novel selective factor Xa inhibitor, DJT06001, which reduces thrombus formation with low risk of bleeding.
Hu X; Xiao Y; Yu C; Zuo Y; Yang W; Wang X; Gu B; Li J
Eur J Pharmacol; 2018 Apr; 825():85-91. PubMed ID: 29475063
[TBL] [Abstract][Full Text] [Related]
12. Alteration in endothelial permeability occurs in response to the activation of PAR2 by factor Xa but not directly by the TF-factor VIIa complex.
Benelhaj NE; Maraveyas A; Featherby S; Collier MEW; Johnson MJ; Ettelaie C
Thromb Res; 2019 Mar; 175():13-20. PubMed ID: 30677622
[TBL] [Abstract][Full Text] [Related]
13. Coagulation factor Xa signaling: the link between coagulation and inflammatory bowel disease?
Borensztajn K; Peppelenbosch MP; Spek CA
Trends Pharmacol Sci; 2009 Jan; 30(1):8-16. PubMed ID: 19058861
[TBL] [Abstract][Full Text] [Related]
14. Blood coagulation factor Xa as an emerging drug target.
Borensztajn K; Spek CA
Expert Opin Ther Targets; 2011 Mar; 15(3):341-9. PubMed ID: 21250873
[TBL] [Abstract][Full Text] [Related]
15. Activated clotting factor X mediates mitochondrial alterations and inflammatory responses via protease-activated receptor signaling in alveolar epithelial cells.
Bukowska A; Schild L; Bornfleth P; Peter D; Wiese-Rischke C; Gardemann A; Isermann B; Walles T; Goette A
Eur J Pharmacol; 2020 Feb; 869():172875. PubMed ID: 31877279
[TBL] [Abstract][Full Text] [Related]
16. Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice.
Posthuma JJ; Posma JJN; van Oerle R; Leenders P; van Gorp RH; Jaminon AMG; Mackman N; Heitmeier S; Schurgers LJ; Ten Cate H; Spronk HMH
Sci Rep; 2019 Mar; 9(1):3909. PubMed ID: 30846818
[TBL] [Abstract][Full Text] [Related]
17. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
[TBL] [Abstract][Full Text] [Related]
18. Coagulation signalling following tissue injury: focus on the role of factor Xa.
Krupiczojc MA; Scotton CJ; Chambers RC
Int J Biochem Cell Biol; 2008; 40(6-7):1228-37. PubMed ID: 18420447
[TBL] [Abstract][Full Text] [Related]
19. Formation of tissue factor-factor VIIa-factor Xa complex induces activation of the mTOR pathway which regulates migration of human breast cancer cells.
Jiang X; Zhu S; Panetti TS; Bromberg ME
Thromb Haemost; 2008 Jul; 100(1):127-33. PubMed ID: 18612547
[TBL] [Abstract][Full Text] [Related]
20. Role of current and emerging antithrombotics in thrombosis and cancer.
Mousa SA
Drugs Today (Barc); 2006 May; 42(5):331-50. PubMed ID: 16801996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
